PPP1R12B
protein-codingprotein phosphatase 1 regulatory subunit 12B, the group of Myosin phosphatase targeting family|Protein phosphatase 1 regulatory subunits|Ankyrin repeat domain containing
Gene summary
Myosin phosphatase is a protein complex comprised of three subunits: a catalytic subunit (PP1c-delta, protein phosphatase 1, catalytic subunit delta), a large regulatory subunit (MYPT, myosin phosphatase target) and small regulatory subunit (sm-M20). Two isoforms of MYPT have been isolated--MYPT1 and MYPT2, the first of which is widely expressed, and the second of which may be specific to heart, skeletal muscle, and brain. Each of the MYPT isoforms functions to bind PP1c-delta and increase phosphatase activity. This locus encodes both MYTP2 and M20. Alternatively spliced transcript variants encoding different isoforms have been identified. Related pseudogenes have been defined on the Y chromosome. [provided by RefSeq, Oct 2011]
- MYPT2
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~244.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0100038
Submitter: LiferaOmics
Genetic evidence – Published PMID: 37644014 – Family 1 – one proband. Case-level (biallelic predicted null in AR model; canonical splice donor +1 variant; homozygous; no consanguinity information → no −0.5 applied) = 1.5; Segregation = 0; Case-control = 0 Family 1 total = 1.5 PMID: 37644014 total = 1.5 Published genetic evidence total = 1.5 / 12 Genetic evidence – Our case Family 1 – one proband. Case-level (biallelic predicted null in AR model; canonical splice donor +1 variant; homozygous scored once; consanguinity −0.5 applied) = (1.5 − 0.5) = 1.0; Segregation = 0; Case-control = 0 Family 1 total = 1.0 Our case contribution = 1.0 / 12 Total genetic evidence (published AR + our case) Published genetic evidence: 1.5 Our additional case: 1.0 Total genetic evidence = 2.5 / 12 Experimental evidence – Published No disease-specific experimental evidence (functional alteration in patient cells, model organism, rescue, etc.) has been identified for PPP1R12B in autosomal recessive neurodevelopmental disorder. Experimental evidence total = 0 / 6 Overall score Genetic evidence = 2.5 Experimental evidence = 0 Overall score = 2.5 / 18
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PPP1R12B variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_002481.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 2 | 7 | |||
| missense | 125 | 5 | 130 | |||
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 4 | 4 | ||||
| Total | 0 | 0 | 136 | 7 | 0 | 143 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_002472.2 | 24 | MANE Select | |
| Ensembl | ENSP00000476755.1 | 24 | MANE Select | |
| RefSeq | NP_001161329.1 | 10 | Standard | |
| RefSeq | NP_001161330.1 | 9 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Focal adhesion - Homo sapiens (human)
- Oxytocin signaling pathway - Homo sapiens (human)
- Regulation of actin cytoskeleton - Homo sapiens (human)
- Vascular smooth muscle contraction - Homo sapiens (human)
- Proteoglycans in cancer - Homo sapiens (human)
Biological Process
- regulation of muscle contraction
- signal transduction
- positive regulation of catalytic activity
- negative regulation of catalytic activity
Molecular Function
- enzyme inhibitor activity
- protein binding
- enzyme activator activity
- phosphatase regulator activity
- protein kinase binding
Cellular Component
- nucleoplasm
- cytoplasm
- cytosol
- cytoskeleton
- Z disc
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000608999
- Coding exons
- 24
- Length
- 244008
- Individuals with no LoFs
- 125690
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 58
- Defined
- 125748
- p
- 0.000231
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.972 | 476 | 540 | 0.882 | 0.0000285 | 6373 |
| Missense (PolyPhen) | 143 | 180.81 | 0.79088 | 1994 | ||
| Synonymous | 1.54 | 169 | 196 | 0.860 | 0.00000967 | 1932 |
| Loss of Function | 4.77 | 18 | 56.8 | 0.317 | 0.00000309 | 656 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.00026 | 0.00026 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0.00023 | 0.00023 | rare |
| European (Non-Finnish) | 0.00027 | 0.00026 | rare |
| South Asian | 0.00017 | 0.00016 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Regulates myosin phosphatase activity. Augments Ca(2+) sensitivity of the contractile apparatus. {ECO:0000269|PubMed:11067852, ECO:0000269|PubMed:9570949}.;
Recessive Scores
- pRec
- 0.108
Intolerance Scores
- LoFtool
- 0.896
- RVIS EVS
- -0.86
- RVIS percentile EVS
- 10.95
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.940
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |